Cargando…

Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics

PURPOSE: Type 2 diabetes mellitus (T2DM) with distal symmetric polyneuropathy (DSPN) is a disease involving the nervous system caused by metabolic disorder, while the metabolic spectrum and key metabolites remain poorly defined. METHODS: Plasma samples of 30 healthy controls, 30 T2DM patients, and 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, J., Cai, M., Wang, Z., Chen, Q., Han, X., Tian, J., Jin, S., Yan, Z., Li, Y., Lu, B., Lu, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105673/ https://www.ncbi.nlm.nih.gov/pubmed/36282471 http://dx.doi.org/10.1007/s40618-022-01929-w

Ejemplares similares

Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes
por: Smith, Sasha, et al.
Publicado: (2022)

Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy
por: Tesfaye, Solomon, et al.
Publicado: (2013)

Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy
por: Kasznicki, Jacek
Publicado: (2014)

Recent advances in the management of diabetic distal symmetrical polyneuropathy
por: Tesfaye, Solomon
Publicado: (2011)

Ultra‐high performance liquid chromatography coupled to tandem mass spectrometry‐based metabolomics study of diabetic distal symmetric polyneuropathy
por: Xu, Jiahui, et al.
Publicado: (2023)

Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke
por: Yu, Fang, et al.
Publicado: (2021)

Accuracy of the Neuropad Test for the Diagnosis of Distal Symmetric Polyneuropathy in Type 2 Diabetes
por: Papanas, Nikolaos, et al.
Publicado: (2011)

The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus
por: Papanas, Nikolaos, et al.
Publicado: (2019)

Association of glycemic variability and hypoglycemia with distal symmetrical polyneuropathy in adults with type 1 diabetes
por: Shen, Ziyang, et al.
Publicado: (2021)

Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review
por: Galosi, Eleonora, et al.
Publicado: (2021)

Skin Intrinsic Fluorescence Correlates With Autonomic and Distal Symmetrical Polyneuropathy in Individuals With Type 1 Diabetes
por: Conway, Baqiyyah N., et al.
Publicado: (2011)

Distal Symmetric Polyneuropathy Identification in Type 2 Diabetes Subjects: A Random Forest Approach
por: Maeda-Gutiérrez, Valeria, et al.
Publicado: (2021)

Screening tests for distal symmetrical polyneuropathy in Latin American patients with type 2 diabetes mellitus
por: Gómez-Banoy, Nicolás, et al.
Publicado: (2017)

Diabetic Distal Symmetric Sensorimotor Polyneuropathy: A Proposal of New Electrodiagnostic Evaluation
por: Lee, Hang Jae, et al.
Publicado: (2023)

Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia
por: Andrade, Fernando, et al.
Publicado: (2021)

Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus
por: Weng, Yi-Ching, et al.
Publicado: (2020)

Influence of Diabetic Distal Symmetric Polyneuropathy on the Performance of the Musculoskeletal System of Lower Leg and Foot
por: Bursac, Snjezana Novakovic, et al.
Publicado: (2019)

The association between distal symmetric polyneuropathy in diabetes with all-cause mortality – a meta-analysis
por: Vági, Orsolya E., et al.
Publicado: (2023)

Impact of Plasma Xanthine Oxidoreductase Activity on the Mechanisms of Distal Symmetric Polyneuropathy Development in Patients with Type 2 Diabetes
por: Fujishiro, Midori, et al.
Publicado: (2021)

Corneal confocal microscopy in patients with distal symmetric polyneuropathy compared to controls
por: Pupe, Camila, et al.
Publicado: (2022)

Randomized Controlled Trial of Physical Exercise in Diabetic Veterans With Length-Dependent Distal Symmetric Polyneuropathy
por: Stubbs, Evan B., et al.
Publicado: (2019)

Proximal Neuropathic Lesions in Distal Symmetric Diabetic Polyneuropathy: Findings of high-resolution magnetic resonance neurography
por: Pham, Mirko, et al.
Publicado: (2011)

Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure
por: Zong, Xiao, et al.
Publicado: (2022)

Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure
por: Zhang, Zhendong, et al.
Publicado: (2023)

Impaired Distal Thermoregulation in Diabetes and Diabetic Polyneuropathy
por: Rutkove, Seward B., et al.
Publicado: (2009)

Relationship between subclinical hypothyroidism and distal-symmetric diabetic polyneuropathy in type 2 diabetes mellitus referred to Kosar Hospital in Semnan and related indicators in 2019–2020
por: Reshdat, Sara, et al.
Publicado: (2022)

Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy
por: Karlsson, Pall, et al.
Publicado: (2021)

Strength exercise for balance and gait in HIV-associated distal symmetrical polyneuropathy: A randomised controlled trial
por: Yakasai, Abdulsalam M., et al.
Publicado: (2021)

Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events
por: Wang, Xiaofeng, et al.
Publicado: (2021)

Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate
por: Mokhtarani, M., et al.
Publicado: (2015)

Association of Cardiovascular Autonomic Neuropathy and Distal Symmetric Polyneuropathy with All-Cause Mortality: A Retrospective Cohort Study
por: Vági, Orsolya E., et al.
Publicado: (2021)

Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy‐Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study
por: Themistocleous, Andreas C., et al.
Publicado: (2022)

Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke
por: Yu, Fang, et al.
Publicado: (2021)

Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis
por: Fang, Chen, et al.
Publicado: (2022)

Chinese herbal medicine TangBi Formula treatment of patients with type 2 diabetic distal symmetric polyneuropathy disease: study protocol for a randomized controlled trial
por: Jin, De, et al.
Publicado: (2017)

Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19)
por: Ghiasvand, Fereshteh, et al.
Publicado: (2020)

Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial
por: Hosseini, Frahad, et al.
Publicado: (2019)

Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis
por: Fu, Yuan, et al.
Publicado: (2022)

Corneal Nerve Loss Detected With Corneal Confocal Microscopy Is Symmetrical and Related to the Severity of Diabetic Polyneuropathy
por: Petropoulos, Ioannis N., et al.
Publicado: (2013)

Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review
por: Carvajal-Moreno, Lidia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ghcdl861h8gpjnvcrechbg4ilm